(May 10, 2012) In July 1999, the U.S. Food and Drug Administration (FDA) approved the drug pioglitazone, manufactured by Takeda and Eli Lilly and Company, as Actos, to help treat type 2 diabetic patients.
A two-year...
Actos Litigation Update
Thousands of patients who have been prescribed the diabetes drug, Actos, have filed lawsuits for serious adverse side effects after taking the drug for more than one year.
Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals for...
Actos Manufacturer Takeda Pharmaceuticals Gets $6.5 Million Actos Award Overturned
Actos, a highly controversial diabetes medication, has been linked to an increased risk of bladder cancer. The Japanese-based company Takeda Pharmaceuticals, which held a patent on Actos, is now facing 3,300 bladder cancer related suits.
The...